8-KFiled Aug 4, 8:00 PM ET

RxSight, Inc. Reports Results for Quarter Ended June 30, 2026

$RXST · RxSight, Inc.

Research Summary

AI-generated summary of this SEC filing

Updated

RxSight, Inc. Reports Results for Quarter Ended June 30, 2026

What Happened
RxSight, Inc. announced its results of operations and financial condition for the three months ended June 30, 2026 in a press release issued and furnished on August 5, 2026. The press release is attached to the Form 8‑K as Exhibit 99.1, and the report was signed by Chief Financial Officer Mark Wilterding.

Key Details

  • Filing date: August 5, 2026; reporting period: quarter ended June 30, 2026.
  • Item reported: 2.02 (Results of Operations and Financial Condition); press release furnished as Exhibit 99.1.
  • Exhibit 104 (Cover Page Interactive Data File in inline XBRL) was included with the report.
  • Form 8‑K was signed by CFO Mark Wilterding on behalf of the company.

Why It Matters
This Form 8‑K furnishes RxSight’s quarterly operating results to the public; the attached press release will contain the detailed figures (revenue, income, and other metrics) investors use to assess performance. Retail investors should read the Exhibit 99.1 press release and any subsequent filings for the specific numbers and context.